Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Esmolol: a unique beta adrenergic antagonist.

S M Maree1

  • 1Nurse Anesthesia Program, North Carolina Baptist Hospital, Winston-Salem 27103.

The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses
|April 1, 1990
PubMed
Summary

Esmolol, a newer beta blocker, offers advantages like rapid action and selectivity for cardiac and noncardiac conditions. Its use is particularly beneficial in acute care settings.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preliminary investigation into the effects of electrical stimulation on mandibular distraction osteogenesis in goats.

International journal of oral and maxillofacial surgery·2003
Same author

Complications associated with diabetes mellitus.

CRNA : the clinical forum for nurse anesthetists·1993
Same author

Acute adrenal insufficiency: a case report.

CRNA : the clinical forum for nurse anesthetists·1993
Same author

The human immunodeficiency virus: knowledge and precautions among anesthesiology personnel.

Journal of clinical anesthesia·1992
Same author

How to boost the odds of a painless i.v. start.

The American journal of nursing·1992
Same author

Report of the National Commission on Nurse Anesthesia Education. An analysis of the cost of nurse anesthesia programs.

AANA journal·1991

Area of Science:

  • Pharmacology
  • Cardiovascular Medicine

Background:

  • Beta adrenergic antagonists, including propranolol, have been mainstays in treating cardiac and noncardiac disorders since the 1970s.
  • The evolution of beta blockers aims to improve efficacy and safety profiles for diverse clinical applications.

Purpose of the Study:

  • To highlight the advantages of esmolol, a recently introduced beta blocker.
  • To discuss the clinical utility of esmolol, particularly in acute care settings.

Main Methods:

  • Review of pharmacological properties of esmolol.
  • Comparison of esmolol with other beta blockers based on available clinical data.

Main Results:

  • Esmolol exhibits rapid onset and elimination, distinguishing it from older beta blockers.
  • Esmolol possesses beta selectivity, potentially leading to a more targeted therapeutic effect.
  • The pharmacokinetic profile of esmolol supports its use in situations requiring precise titration.

Conclusions:

  • Esmolol represents a significant advancement in beta blocker therapy.
  • Its rapid action, selectivity, and favorable elimination profile make it highly suitable for acute care environments.
  • Further research may explore expanded applications for esmolol in managing various cardiovascular and noncardiovascular conditions.

Related Experiment Videos